HYPERION THERAPEUTICS INC COM STK (HPTX)

Sector:
MATERIALS
Industry:
MATERIALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
N/A
Employees:
80
2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA 94005
650-745-7802

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Hyperion Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat orphan diseases in the United states, Canada, and internationally.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 328.04 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.02
Price to Revenue4.3253 Debt to Equity0.1378 EBITDA1.24 Million
Price to Book Value3.7345 Operating Margin-3.7039000000000004 Enterprise Value362.896 Million
Current Ratio5.243 EPS Growth-1.388 Quick Ratio5.005
1 Yr BETA 1.0591 52-week High/Low 0.0 / Profit Margin-5.5069
Operating Cash Flow Growth2657.5908 Altman Z-Score6.4321 Free Cash Flow to Firm 3.79 Million
View SEC Filings from HPTX instead.

View recent insider trading info

Funds Holding HPTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HPTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BARRIS PETER J

  • 10% Owner
No longer subject to file 2015-05-07 0

SOFINNOVA VENTURE PARTNERS VII L P

SOFINNOVA MANAGEMENT VII, L.L.C.

BUATOIS ERIC

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2015-05-07 0

WELCH DANIEL G

  • Director
No longer subject to file 2015-05-07 0

BARRETT M JAMES

  • 10% Owner
No longer subject to file 2015-05-07 0

KERINS PATRICK J

  • 10% Owner
No longer subject to file 2015-05-07 0

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2015-05-07 0

HEALY JAMES

  • Director
  • 10% Owner
No longer subject to file 2015-05-07 0

KOLLURI KRISHNA KITTU

  • 10% Owner
No longer subject to file 2015-05-07 0

BASKETT FOREST

  • 10% Owner
No longer subject to file 2015-05-07 0

ZOTH LOTA S.

  • Director
No longer subject to file 2015-05-07 0

SANTEL DONALD J CEO & PRESIDENT

  • Officer
  • Director
No longer subject to file 2015-05-07 0

DRANT RYAN D

  • 10% Owner
No longer subject to file 2015-05-07 0

SCHROEDER THEODORE R

  • Director
No longer subject to file 2015-05-07 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

  • 10% Owner
No longer subject to file 2015-05-07 0

FARROW JEFFREY S CFO

  • Officer
No longer subject to file 2015-05-07 0

NUNN JASON RALEIGH

  • Director
No longer subject to file 2015-05-07 0

SALEHIZADEH BIJAN

  • Director
No longer subject to file 2015-05-07 0

HANSEN BO JESPER

  • Director
No longer subject to file 2015-05-07 0

SCHARSCHMIDT BRUCE FREDERICK SVP & CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2015-05-07 0

NASH CHRISTINE A SVP & CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2015-05-07 0

HOLLES NATALIE C. SVP, BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2015-05-07 0

GOULD ASHLEY C. SVP GOVT AFF & CHIEF LEGAL OFC

  • Officer
No longer subject to file 2015-05-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments